September 06, 2013
Avanir Pharmaceuticals Inc. said Friday it has reached a settlement with Wockhardt Ltd. over its planned generic version of mental health drug Nuedexta, ending a patent infringement dispute in Delaware federal court.
August 30, 2011
Avanir Pharmaceuticals Inc. on Tuesday sued drugmaker Wockhardt Ltd. in an effort to block its plans to make a generic version of mental health drug Nuedexta, marking the latest complaint in a campaign of patent suits over the drug.